cabergoline has been researched along with oxytocin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Du, Y; Lin, XM; Ma, YS; Ni, J; Tang, YY; Zhou, J | 1 |
| Erbas, O; Hortu, I; Karadadas, E; Ozceltik, G; Tavmergen Goker, EN; Tavmergen, E; Yigitturk, G | 1 |
1 review(s) available for cabergoline and oxytocin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for cabergoline and oxytocin
| Article | Year |
|---|---|
Relaxant effects of metoclopramide and magnesium sulfate on isolated pregnant myometrium: an in vitro study.
Topics: Adult; Cabergoline; Dopamine Agonists; Dopamine Antagonists; Ergolines; Female; Humans; In Vitro Techniques; Magnesium Sulfate; Metoclopramide; Muscle Relaxation; Myometrium; Oxytocin; Pregnancy; Tocolytic Agents; Uterine Contraction | 2014 |
Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model.
Topics: Animals; Cabergoline; Disease Models, Animal; Female; Ovarian Hyperstimulation Syndrome; Oxytocics; Oxytocin; Rats; Rats, Sprague-Dawley; Rats, Wistar; Vascular Endothelial Growth Factor A | 2021 |